HOME >> BIOLOGY >> NEWS
UK College of Pharmacy to develop treatments for people exposed to dirty bomb

LEXINGTON, KY (Oct. 18, 2005) -- Researchers from the University of Kentucky College of Pharmacy's Center for Pharmaceutical Science and Technology (CPST), in partnership with ChemPharma International, a Richmond-based pharmaceutical company, have received $1.2 million in funding from the National Institutes of Health (NIH) to develop treatments to be used in radiation emergencies such as after exposure to dirty bombs.

"In addition to protecting the citizens of Kentucky and the U.S. from terrorist attacks, this contract is an important step in UK being recognized as ethe place' where new drug molecules for the treatment of nuclear or bioterrorism exposures are developed into pharmaceutical products and undergo clinical testing," said Michael Jay, Ph.D., principal investigator of the study and director of the CPST.

In May, the NIH's National Institute of Allergy and Infectious Diseases (NIAID) solicited proposals to develop alternative formulations or delivery methods that help clear the body of radioactive elements like plutonium to be used in a mass exposure situation. According to the NIAID, the potential for radiation exposures to occur from terrorists acts, radiation accidents or nuclear detonation mandates that the health care system develop and implement preparedness plans that include the stockpiling of radioprotective drugs and therapeutics.

Currently, radioactive materials must be removed from the body by administering intravenous drugs. However, researchers from UK and ChemPharma are proposing to develop an orally administered dosage formulation with the ultimate goal of identifying an effective treatment for inclusion in the Strategic National Stockpile. The funding award is for $1,204,374 during the next 21 months.

The NIAID is facilitating the development of this project because oral formulations -- such as capsules or tablets -- would be easier to distribute and administer during a mass exposure situation.


'"/>

Contact: Louise DuPont
mldupo00@email.uky.edu
859-323-6363
University of Kentucky
18-Oct-2005


Page: 1 2 3

Related biology news :

1. CSHL awarded Pre-College Science Education Grant by HHMI
2. 454 Life Sciences and Baylor College of Medicine complete sequencing of DNA pioneer
3. Nobel laureate James Watson receives personal genome in ceremony at Baylor College of Medicine
4. Hamilton College researchers discover molecules with potential to treat breast cancer
5. AEA, UAlbany College of Nanoscale Science and Engineering to partner on CIRCA 07
6. Granthams to fund Institute for Climate Change at Imperial College London
7. Vet College gets grant to develop fish virus diagnostic technique
8. Rutgers College of Nursing dean authors a book on genetics and how it affects nursing and health
9. Williams College biologist explores photosynthetic apparatus
10. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device
11. American College of Medical Genetics -- 2007 Annual Clinical Genetics Meeting Announcement

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 online post, ... Dr. James L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company ... on June 16 that starting July 5 it would begin offering free ...
(Date:6/11/2020)... ... 08, 2020 , ... Cryo-Cell International’s announcement comes on the ... in the medical field. The face masks will be distributed nationwide to obstetrical ... day to provide healthcare to pregnant women. The delivery of masks is scheduled ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... software developer and solutions provider, today reported that the implementation of browser-based, ... compliance by 100%, resulting in greater efficiency for global biotechnology company, bioMérieux. ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... 2020 , ... The Indoor Lab, a leading provider of sensor solutions for ... types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using ... will provide a health performance index system that scores all aspects of compliance similar ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , ... today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. ... studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... offering an Amniosomes special offer. This includes buy three, get the fourth unit ... (888) 568-6909. , Amniotic derived exosomes, known as exosomes, have been a game ...
Breaking Biology Technology:
Cached News: